GSA Capital Partners’s EyePoint Pharmaceuticals EYPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $939K | Buy |
+99,764
| New | +$939K | 0.07% | 501 |
|
|
2024
Q4 | – | Sell |
-32,979
| Closed | -$264K | – | 1726 |
|
|
2024
Q3 | $264K | Buy |
32,979
+18,616
| +130% | +$149K | 0.02% | 1283 |
|
|
2024
Q2 | $125K | Buy |
+14,363
| New | +$125K | 0.01% | 1512 |
|
|
2023
Q1 | – | Sell |
-46,050
| Closed | -$161K | – | 1595 |
|
|
2022
Q4 | $161K | Buy |
46,050
+24,121
| +110% | +$84.3K | 0.02% | 1235 |
|
|
2022
Q3 | $173K | Buy |
+21,929
| New | +$173K | 0.02% | 1268 |
|
|
2021
Q1 | – | Sell |
-104,089
| Closed | -$685K | – | 1217 |
|
|
2020
Q4 | $685K | Buy |
104,089
+91,436
| +723% | +$602K | 0.11% | 256 |
|
|
2020
Q3 | $66K | Buy |
+12,653
| New | +$66K | 0.01% | 1167 |
|
|
2016
Q4 | – | Sell |
-14,796
| Closed | -$445K | – | 1815 |
|
|
2016
Q3 | $445K | Sell |
14,796
-730
| -5% | -$22K | 0.02% | 1123 |
|
|
2016
Q2 | $439K | Sell |
15,526
-2,480
| -14% | -$70.1K | 0.02% | 1152 |
|
|
2016
Q1 | $483K | Buy |
18,006
+11,297
| +168% | +$303K | 0.03% | 1042 |
|
|
2015
Q4 | $323K | Buy |
6,709
+3,418
| +104% | +$165K | 0.02% | 1421 |
|
|
2015
Q3 | $120K | Buy |
+3,291
| New | +$120K | 0.01% | 1642 |
|
|
2015
Q2 | – | Sell |
-1,470
| Closed | -$58K | – | 2014 |
|
|
2015
Q1 | $58K | Buy |
+1,470
| New | +$58K | ﹤0.01% | 2052 |
|